(Q24246665)

26 November 2023

Conal Daly

2

C

Daly

1 reference

26 November 2023

Marion K Campbell

3

M

Campbell

1 reference

26 November 2023

Cam Donaldson

4

C

Donaldson

1 reference

26 November 2023

Izhar Khan

5

I

Khan

1 reference

26 November 2023

Luke Vale

6

L

Vale

1 reference

26 November 2023

Sheila A Wallace

7

S

Wallace

1 reference

26 November 2023

Alison M MacLeod

8

A

Macleod

1 reference

Cochrane Database of Systematic Reviews

26 November 2023

language of work or name

1 reference

20 July 2005

0 references

published in

0 references

cites work

Subcutaneous treatment with recombinant human erythropoietin--the influence of injection frequency and skin-fold thickness.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Once-weekly compared with three-times-weekly subcutaneous epoetin beta: results from a randomized, multicenter, therapeutic-equivalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Cloning and expression of the human erythropoietin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Implications of recombinant erythropoietin therapy for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Safety and efficacy of erythropoietin in children with chronic renal failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

A rationale for an individualized administration frequency of epoetin beta: a pharmacological perspective

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Erythropoietin-induced elevation in blood pressure is immediate and dose dependent

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus three times a week administration in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003895.PUB2

7 January 2021

10.1002/14651858.CD003895.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_og2mywfovjc2tertac3xq6pq4y

0 references